The size of the MEA Aesthetic/Cosmetic Lasers Market was around USD 27.31 million in 2022. It is expected to grow at a CAGR of 9.4% to reach USD 42.79 million by 2027. Thus, it captures a meager 3% of the global market share.
High growth in aesthetic medical laser systems and the rise in government initiatives regarding aesthetic procedures are primarily accelerating the development of the cosmetic lasers market in MEA. Rising disposable incomes, medical tourism, technology advancements, and a constantly increasing preference for non-invasive cosmetic operations drive this market further. In addition, social media have positively influenced the growth of aesthetic medical laser systems in the Middle East and Africa. Saudi women have been undergoing more cosmetic procedures than ever before. As a result, it has become a common practice among women and men to undergo cosmetic procedures. Additionally, Saudi Arabia has seen a significant rise in aesthetic clinics. Saudi Arabia has several aesthetic clinics, including Derma Clinic, Dr.Areej Meer Clinic, and Cosmodrome Clinics that offer cosmetic surgery, laser procedures, skin rejuvenation, and scar removal treatments.
The UAE's aesthetic medical laser systems market has a wide range of potential opportunities. The country's expanding healthcare infrastructure has boosted dermatological and cosmetic operations, which has propelled the demand for aesthetic medical laser systems.
However, the MEA cosmetic lasers market is expected to be restrained by a complex administrative framework and a lack of reimbursement. The countries such as UAE, South Africa, and Saudi Arabia have implemented a lockdown and social distancing policy. This trend hinders access to work, regular income, payments, fairs, schools, and healthcare. This has resulted in losses that the countries are struggling to recover from. In addition, it is believed the lockdown has negatively impacted the non-emergency medical services in the region, affecting the aesthetic sector.
This research report on the Middle East and Africa cosmetic lasers market has been segmented and sub-segmented into the following categories:
By End User:
Cosmetics businesses in this area have been significantly affected by the epidemic. As a result of its dependence on global suppliers, the market is constrained. In November 2020, a second outbreak of the virus had hit the region. Access restrictions were re-imposed as a result. Tourists in the area are increasingly attracted to Saudi Arabia and the United Arab Emirates. However, restaurants, cinemas, and some healthcare facilities are subject to a curfew until vaccinations are more widely available. This is impeding this regional market expansion.
COVID-19 has a negative impact on socioeconomic circumstances in the Middle East. Yet, despite this, the countries managed to contain the COVID-19 epidemic and prevent the disease from spreading.
During this time, Saudi Arabia ruled the MEA Cosmetic Lasers Market. There are several reasons for this, including an increase in the number of aesthetic surgeries performed in the country, an increase in the geriatric population, increased public and private initiatives to raise awareness of minimally invasive aesthetic procedures, and an increase in the number of public and private initiatives to raise awareness of minimally invasive aesthetic procedures. As a result, the number of laser cosmetic surgery treatments performed in the United States has significantly increased in recent years. According to the International Society of Plastic Surgery (ISAPS) research in 2018, Saudi Arabia was rated 30th globally with the most significant number of cosmetic treatments. This suggests that the country has more demand for Cosmetic Lasers due to the increase in cosmetic procedures.
KEY MARKET PLAYERS:
Companies playing a significant role in the MEA Aesthetic/Cosmetic Lasers Market are Aerolase (U.S.), Alma Lasers, Ltd. (Israel), Cutera, Inc. (U.S.), Cynosure, Inc. (U.S.), El. En. SpA (Italy), Lumenis Ltd. (Israel), Sciton, Inc. (U.S.), SharpLight Technologies (Israel), Syneron Medical Inc. (Israel), and Solta Medical (U.S.).
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com